The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis

BACKGROUND: Until now, there is no effective anti-fibrotic therapy available for liver cirrhosis. Stem cell therapies have been studied for the treatment of hepatic fibrosis. However, the use of embryonic stem cells or induced pluripotent stem cells (iPSC) has limitations such as ethical concern or...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stem Cell Res Ther
Autori principali: Park, Suhyun, In Hwang, Seon, Kim, Jonghun, Hwang, Seoyeon, Kang, Sohee, Yang, Sera, Kim, Jonghwa, Kang, Wonseok, Kim, Kyun-Hwan, Han, Dong Wook, Paik, Yong-Han
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6330392/
https://ncbi.nlm.nih.gov/pubmed/30635054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-018-1127-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi